Atorvastatin News and Research

RSS
Esperion Therapeutics reports positive results from ETC-1002 Phase 2a study for LDL-C treatment

Esperion Therapeutics reports positive results from ETC-1002 Phase 2a study for LDL-C treatment

Reimbursement systems appear to impact on achievement of cholesterol lowering targets

Reimbursement systems appear to impact on achievement of cholesterol lowering targets

Study finds that high potency statins can beat dementia

Study finds that high potency statins can beat dementia

Genetic variations in genes could put patients at risk for statin-associated muscle injury: Study

Genetic variations in genes could put patients at risk for statin-associated muscle injury: Study

Stopping cholesterol drugs may increase risk of Parkinson's disease

Stopping cholesterol drugs may increase risk of Parkinson's disease

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

FDA accepts Merck's NDA for NOXAFIL tablets

FDA accepts Merck's NDA for NOXAFIL tablets

Coenzyme Q10 offsets cellular changes that are linked to side-effect of some statin drugs: Study

Coenzyme Q10 offsets cellular changes that are linked to side-effect of some statin drugs: Study

Study evaluates efficacy of drug combinations in treating colorectal cancer

Study evaluates efficacy of drug combinations in treating colorectal cancer

High-dose rosuvastatin reduces acute kidney injury caused by imaging dye in ACS patients

High-dose rosuvastatin reduces acute kidney injury caused by imaging dye in ACS patients

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

FDA acknowledges resubmission of Merck’s NDA for ezetimibe and atorvastatin tablets

FDA acknowledges resubmission of Merck’s NDA for ezetimibe and atorvastatin tablets

Monoclonal antibody boosts cholesterol reduction

Monoclonal antibody boosts cholesterol reduction

Monoclonal antibody boosts cholesterol reduction

Monoclonal antibody boosts cholesterol reduction

Teva third quarter 2012 net revenues increase 14% to $5.0 billion

Teva third quarter 2012 net revenues increase 14% to $5.0 billion

Intensive treatment with high doses of statin drugs shows promise for dyslipidemia

Intensive treatment with high doses of statin drugs shows promise for dyslipidemia

Meijer offers generic Lipitor for free to help families be heart healthy

Meijer offers generic Lipitor for free to help families be heart healthy

Statin's potency may cause muscle problems in patients with cardiovascular disease

Statin's potency may cause muscle problems in patients with cardiovascular disease

Dr. Reddy's launches generic LIPITOR tablets in the U.S.

Dr. Reddy's launches generic LIPITOR tablets in the U.S.

Individuals on statins more likely to experience fatigue with exertion

Individuals on statins more likely to experience fatigue with exertion